Elobixibat

DB12486InvestigationalSmall molecule

Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.

Chemical structure of Elobixibat
Mechanism
Curator reviewed
Formula / weight
C36H45N3O7S2 · 695.89 g/mol (avg)
Code names
A-3309 · AZD-7806

Resolves to

Compound
UNII865UEK4EJCCAS439087-18-0ChEMBLCHEMBL3039515PubChem9939892
Clinical / RWD
ATCA06AX09
Structure
InChIKeyXFLQIRAKKLNXRQ-UUWRZZSWSA-NSMILESCCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)NCC(O)=O)C3=CC=CC=C3)C=C2S(=O)(=O)C1
Targets
Q12908SLC10A2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 8 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Elobixibat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In